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Background. This study assessed the concentration of rocuronium in the cerebrospinal ¯uid
(CSF) of patients undergoing cerebral aneurysm clipping, and investigated whether the mode of
administration (single bolus vs continuous infusion) in¯uenced the CSF concentration.
Methods. Twenty patients with subarachnoid haemorrhage were randomly allocated to
receive a bolus dose (bolus group), or a bolus followed by a continuous infusion of rocuronium
(infusion group) (n=10 for each group). Arterial blood and ventricular CSF were sampled 2 h
after the rocuronium bolus. Samples were analysed by liquid chromatography electrospray
ionization-tandem mass spectrometry.
Results. Rocuronium could be detected in all the CSF samples. The mean (range) CSF concen-
tration was 2.2 (0.9±4.6) ng ml±1 in the bolus group and 12.4 (2.4±34.6) ng ml±1 in the infusion
group; P<0.01.
Conclusions. This study demonstrated that rocuronium, normally not considered to cross
the blood±brain barrier, is regularly found in the CSF of patients undergoing cerebral clipping;
continuous infusion of the drug led to higher plasma and CSF concentrations than after a single
bolus dose.
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Neuronal nicotinic acetylcholine receptors (nAChR) are
ubiquitously present in CNS and involved in chemical
signalling in the brain.1 When given in suf®cient amounts,
neuromuscular blocking agents (NMBA) interact with these
nAChR, leading dose dependently to activation or inhibition
of different nAChR subtypes.2 To estimate the clinical
relevance of this interaction, quantitative data on the
cerebrospinal ¯uid (CSF) concentration of NMBAs are
required. Whilst NMBAs are considered not to cross the
intact blood±brain barrier, these molecules may pass into
the CSF when its function is impaired.3 4 Only a little
information about re-entry of rocuronium, a NMBA used in
neurosurgical patients, into the CSF is available. This, study
aimed ®rst to investigate the CSF concentration of
rocuronium in patients undergoing cerebral aneurysm
clipping, and secondly to assess whether the mode of
administration (single bolus or continuous infusion) has any
in¯uence on its CSF concentration.
Methods and results
The study was approved by the hospital Ethics Committee;
the patients or their next of kin gave informed consent or
assent, respectively. Twenty patients undergoing cerebral
aneurysm clipping with CSF drainage were randomly
allocated to the bolus group or infusion group.
Anaesthesia was induced with thiopentonal (3±5 mg kg±1),
fentanyl (1±2 mg kg±1), and rocuronium (0.6 mg kg±1);
patients in the infusion group also received a continuous
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infusion of rocuronium to maintain constant neuromuscular
block, that is 90±95% twitch depression. Anaesthesia was
maintained with continuous infusions of midazolam (0.05±
0.2 mg kg±1 h±1) and fentanyl (2±5 mg kg±1 h±1). The
patients' lungs were ventilated to normocarbia with
iso¯urane 0.5% and nitrous oxide 60% in oxygen. Before
the beginning of the craniotomy, an external CSF drainage
was placed into the lateral ventricle by the neurosurgeon via
a single bore hole approach.
Baseline arterial blood samples (5 ml), needed to control
to linearity of the analytical method, were taken before
induction of anaesthesia. Baseline CSF samples were
obtained from patients undergoing elective surgery under
spinal anaesthesia. In the ®rst ®ve of 10 patients in each
group, blood and CSF were sampled at 1, 2, and 4 h after the
initial dose of rocuronium. In the second ®ve patients, blood
and CSF were sampled at 2 h. After collection, the samples
were centrifuged at 4°C, and 1 ml of plasma or CSF was
added to tubes containing 0.2 ml of 1 M sodium hydrogen
phosphate solution also as a stabilizer. These samples were
kept frozen at ±70°C until analysis. The concentration of
rocuronium was determined by liquid chromatography
electrospray ionization-tandem mass spectrometry.5 The
detection limit of the method was 0.5 ng ml±1 for
rocuronium in CSF and 5 ng ml±1 for rocuronium in plasma,
and the inter-assay coef®cient of variation was less than 8%.
Data are expressed as individual values or as median or
mean and range. Patient characteristics and rocuronium
concentrations at 2 h in the two groups were compared using
the Mann±Whitney test. The time course of the plasma and
CSF concentration of rocuronium was compared with a one-
way ANOVA for repeated measures followed by a Bonferroni
correction. Differences were considered signi®cant when
P<0.05.
One patient in the infusion group had to be excluded
because of violation of the study protocol. The physical
characteristics and surgical data were comparable between
the two groups (Table 1). Preliminary analysis after 10
patients (®ve in each group) revealed that in the infusion
group the concentration of rocuronium was highest after 2 h;
the corresponding values at 1, 2, and 4 h were 3.8 (2.4±5.3),
5.7 (2.4±13.2) (P<0.05 compared with 1 h), and 3.8 (1.1±
7.5) ng ml±1, respectively, n=5. The respective values in the
bolus group were 2.2 (0.6±7.5), 2.0 (0.9±4.5), and 1.8 (0.7±
4.7) ng ml±1; n.s, n=5. The ®nal analysis demonstrated that
the CSF concentration of rocuronium at 2 h was 2.2 (0.9±
4.6) ng ml±1 in the bolus group (n=10) and 12.4 (2.4±34.6)
ng ml±1 in the infusion group (n=9); P<0.01 (Table 1).
Discussion
In the present study rocuronium could be detected in all CSF
samples, and a continuous infusion led to higher CSF
concentrations than a single bolus dose. In the ®rst ®ve of 10
patients in each group, the time course of CSF penetration of
rocuronium was assessed; we focused on a 4-h period
because it has recently been demonstrated that in the patient
population studied the CSF concentration of NMBA may be
highest at this time point.4 Based on the results of the ®rst
part of the study blood and CSF were only sampled at 2 h in
the second ®ve of 10 patients in each group.
Our results are surprising, as in previous studies NMBAs
were not regularly detected in the CSF. Tassonyi and co-
workers found atracurium in the CSF of only ®ve out of 10
patients undergoing cerebral aneurysm clipping.4 However,
their lower limit of detection was 10 ng ml±1. In the present
study the lower detection limit for rocuronium in the CSF
was 0.5 ng ml±1, allowing quanti®cation of very small
amounts of the drug. Moreover, most studies investigating
the CSF concentration of NMBA have sampled the CSF in
the lumbar subarachnoid space.3 4 Circulation of CSF from
the brain to the lumbar subarachnoid space takes about
90 min, and approximately 0.25% of total CSF volume is
replaced by freshly formed CSF each minute. Thus,
sampling of CSF from the lumbar subarachnoid space
re¯ects neither the time course of the passage of NMBA into
the CSF or its maximum concentration in the CNS. In the
present study, the low detection limit of the analytical
method and sampling directly from the ventricular system
may have contributed to the consistent section of
rocuronium in the CSF.
There is controversy in the literature about the origin of
NMBA detected in the CSF. Eddlestone and co-workers3
thought that the presence of atracurium in the CSF in two
out of 10 patients (80 and 1460 ng ml±1) could be accounted
for by blood contamination. This factor cannot be excluded
in our study. However, CSF containing haemolysed blood
was only observed in one patient. Moreover, the CSF
concentrations of rocuronium were dose-dependent, a
continuous infusion leading to higher concentrations than
a single bolus, and in both groups the CSF concentration
was within a narrow range (Table 1).
Table 1 Physical characteristic, surgical data, and rocuronium plasma and
CSF concentrations. Data are absolute values (sex ratio), mean or median
(range, or SD); n.a., not applicable; *P<0.01. Plasma and CSF concentrations
were determined 2 h after the initial dose of rocuronium. Hunt and Hess
classi®cation: 0, unruptured aneurysm; 1, asymptomatic or minimal headache
and slight nuchal rigidity; 2, moderate to severe headache, nuchal rigidity,
but no neurological de®cit other than cranial nerve palsy; 3, drowsiness,
confusion, or mild focal de®cit; 4, stupor, mild to severe hemiparesis,
possible early decerebrate rigidity, vegetative disturbance; 5, deep coma,
decerebrate rigidity, moribund appearance.10 Time to surgery: time between
diagnosis of subarachnoid haemorrhage and aneurysm clipping
Bolus group Infusion group
(n=10) (n=9)
Gender-ratio (males/females) 5/5 4/5
Age (yr) 48 (38±57) 42 (24±60)
Weight (kg) 75 (61±95) 72 (60±85)
Hunt and Hess classi®cation 2 (0±3) 2 (0±3)
Time to surgery (h) 40 (57) 31 (40)
Duration of rocuronium-infusion (min) n.a. 192 (140±275)
Plasma concentration (ng ml±1) 144 (57±347) 1123 (604±1530)*
CSF concentration (ng ml±1) 2.2 (0.9±4.6) 12.4 (2.4±34.6)*
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There is a dose-dependent relationship between an
NMBA causing inhibition or activation of nAChR. Thus,
the possible clinical consequences of the CSF concentration
of rocuronium measured in this study have to be considered.
Cholinergic neurotransmission plays a role in regulation of
respiratory pattern, and inhibition of nAChR may lead to
central respiratory depression.6 As recently shown, NMBAs
may inhibit the major brain a4b2 human nAChR,2 and thus
lead to central respiratory inhibition. However, the concen-
trations required to produce inhibition of nACh receptors
were in the mM range, being about 1000-fold higher than the
concentrations detected in this study.2 NMBAs may also
produce excitatory CNS effects. Pancuronium and
vecuronium may cause a sustained increase in cytosolic
calcium by initiating prolonged activation of brain nAChR,
thus leading to uncontrolled neuronal excitability and
seizure activity.7 Case reports of accidental intrathecal
injection of NMBAs con®rmed this property.8 9 However,
about 10 000-fold higher concentrations than those
measured in this study were necessary to elicit seizures.6
Thus, according to the current literature, no convincing
evidence exists of major CNS effects from the concentra-
tions of rocuronium found in the CSF in this study.
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